ArticleAnnals of medicine2023
Outcome of transcatheter atrial septal defect closure in a nationwide cohort.
Article in Annals of medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 26 citations in OpenAlex.
- Long-Term Postoperative Outcomes of Sinus Venosus Defect.Journal of clinical medicine · 2026Article
- Efficacy and safety of transseptal puncture-assisted atrial fibrillation ablation in patients with atrial septal occluder devices: an updated systematic review and meta-analysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026Review
- Thrombus on ASD Closure Device Reveals Underlying Thrombophilia.JACC. Case reports · 2026Article
- Article
- Atrial Septal Defects: From Embryology to Pediatric Pulmonary Hypertension.Journal of clinical medicine · 2025Review
- Outcomes Analysis of Transcatheter Closure of Atrial Septal Defects.Journal of the American Heart Association · 2025Article
- Atrial Septal Defect and Heart Rhythm Disorders: Physiopathological Linkage and Clinical Perspectives.Biomedicines · 2025Review
- Bimodal Distribution of Atrial Arrhythmias After Transcatheter Atrial Septal Defect Closure.Journal of the Society for Cardiovascular Angiography & Interventions · 2025Article
- The Evaluation of P-Wave Parameters in Patients With Percutaneous Closure of Atrial Septal Defect.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2025Article
- Secundum atrial septal defect closure in adults in the UK.European heart journal. Quality of care & clinical outcomes · 2025Observational
- Cardiovascular outcomes in adult patients with atrial septal defect: a nationwide population-based study.Frontiers in cardiovascular medicine · 2025Article
- Breaking the Barriers: Transseptal Puncture in Patients with Atrial Septal Defect Closure Devices.Interventional cardiology (London, England) · 2025Review
- Percutaneous atrial septal defect closure in limited-resource setting: a decade-long experience from Ethiopia.Frontiers in cardiovascular medicine · 2025Article
- Long-term outcomes of transcatheter atrial septal defect closure: a single-center retrospective study.Frontiers in cardiovascular medicine · 2024Article
- Arrhythmic Risk and Treatment after Transcatheter Atrial Septal Defect Closure.Diagnostics (Basel, Switzerland) · 2023Review
- Volume overload impedes the maturation of sarcomeres and T-tubules in the right atria: a potential cause of atrial arrhythmia following delayed atrial septal defect closure.Frontiers in physiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranscatheter (TC) atrial septal defect (ASD) closure has been the mainstay of therapy for secundum-type ASDs for over 20 years.
aimsThis nationwide cohort evaluated the long-term outcome of transcatheter-closed ASDs.
methodsThe study enrolled every transcatheter ASD closure performed in Finland from 1999 to 2019. Five age, sex, and municipality-matched controls per ASD patient were gathered from the general population. The median follow-up period was 5.9 years (range 0-20.8). We used the hospital discharge register to gather all hospital visits and diagnoses. Closure complications and echocardiographic changes were collected from the electronic health records.
resultsTranscatheter ASD closure was performed in 1000 patients (68.5% females) during the study period. The median (range) age at the time of the procedure was 37.9 (1.8-87.5) years. ASD patients had an increased risk for new-onset atrial fibrillation (RR 2.45, 95% CI: 1.84-3.25), migraine (RR 3.61, 95% CI: 2.54-5.14), ischemic heart disease (RR 1.73, 95% CI: 1.23-2.45), ventricular fibrillation/tachycardia (RR 3.54 (95% CI: 1.48-8.43) and AV conduction disorder (RR 3.60, 95% CI: 1.94-6.70) compared to the control cohort. Stroke risk was not increased (RR 1.36, 95% CI: 0.91-2.03). Adverse events occurred in 6.3% (
conclusionAfter TC closure of ASD, patients had a higher risk of new-onset atrial fibrillation and migraine
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.